India, July 30 -- image credit- freepik

RPG Life Sciences has announced the execution of a Business Transfer Agreement for the transfer of the company's Active Pharmaceutical Ingredients (API) business to RPG Active Pharma, a wholly owned subsidiary of RPG Life Sciences, as a going concern on a slump sale basis.

The proposed transfer is part of RPG Life Sciences' strategy to create a focused API business with dedicated capital, sharper management attention and greater strategic flexibility, while the company also continues to build its formulations business. This business has been created at a time when the global pharmaceutical supply chains are undergoing structural realignment and India is increasingly emerging as a preferred destina...